PhreesiaPHR -0.92%65 ROC (Joel Greenblatt) % is 125.75% as of Apr. 2026. GuruFocus rates PHR with a GF Score™ of 65/100 and a GF Value™ of $27.02 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Phreesia ranks better than 62.72% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Phreesia's annualized ROC (Joel Greenblatt) % for the quarter that ended in Apr. 2026 was 125.75%.
The historical rank and industry rank for Phreesia's ROC (Joel Greenblatt) % or its related term are showing as below:
PHR'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -487.12 Med: -91.04 Max: 20.3
Current: 20.3
During the past 9 years, Phreesia's highest ROC (Joel Greenblatt) % was 20.30%. The lowest was -487.12%. And the median was -91.04%.
PHR's ROC (Joel Greenblatt) % is ranked better than 62.72% of 668
companies
in the Healthcare Providers & Services industry
Industry Median: 12.47
vs PHR: 20.30
Phreesia's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 32.90% per year.
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
The historical data trend for Phreesia's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PHR vs EVH, CTEV, MDRX: ROC (Joel Greenblatt) % Comparison
For the Health Information Services subindustry, Phreesia's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Phreesia ROC (Joel Greenblatt) % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Phreesia's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Phreesia's ROC (Joel Greenblatt) % falls into.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Apr. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 125.75% mean?
Phreesia (PHR) has a ROC (Joel Greenblatt) % of 125.75% as of Apr. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Phreesia and its competitors. According to the industry distribution chart, Phreesia ranks #249 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 37.3%.
Is Phreesia's ROC (Joel Greenblatt) % too high?
Phreesia's current ROC (Joel Greenblatt) % is 125.75%. The Healthcare Providers & Services industry median ROC (Joel Greenblatt) % is 12.47. Phreesia's value of 125.75% is 908.4% above this industry median. Based on the distribution chart, Phreesia ranks #249 out of 668 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Phreesia has a GF Score™ of 65/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Phreesia's ROC (Joel Greenblatt) % compare to EVH and CTEV?
According to the Healthcare Providers & Services industry distribution chart, Phreesia ranks #249 out of 668 companies for ROC (Joel Greenblatt) %. This puts Phreesia in the upper half of its industry. The industry median ROC (Joel Greenblatt) % is 12.47. Phreesia's value of 125.75% is 908.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Healthcare Providers & Services company?
The median ROC (Joel Greenblatt) % among Healthcare Providers & Services companies is 12.47, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Phreesia's current ROC (Joel Greenblatt) % of 125.75% is 908.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Phreesia and its competitors. For the Healthcare Providers & Services industry, the median ROC (Joel Greenblatt) % is 12.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Phreesia's current ROC (Joel Greenblatt) % is 125.75%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Phreesia stock overvalued right now?
Based on GuruFocus' analysis, Phreesia (PHR) is currently considered Possible Value Trap. The stock's GF Value™ is $27.02, compared to a current price of $10.72 — trading 60.3% below its estimated fair value. The current ROC (Joel Greenblatt) % is 125.75% and 908.4% above the Healthcare Providers & Services industry median of 12.47. Phreesia's overall GF Score™ is 65/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Phreesia (PHR), the current ROC (Joel Greenblatt) % is 125.75% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Phreesia (PHR) Overvalued in 2026?
Based on GuruFocus' analysis, Phreesia stock appears to be undervalued.
The current stock price of $10.72 is trading 60.3% below its estimated GF Value™ of $27.02.
GuruFocus considers Phreesia to be Possible Value Trap.
Key valuation signals for PHR:
ROC (Joel Greenblatt) %: 125.75%
GF Value™: $27.02 vs. price of $10.72 (60.3% below fair value)
Industry Position: 908.4% above the Healthcare Providers & Services median (#249 of 668)
No single metric tells the full story. See the PHR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Phreesia Inc is a provides an integrated software, payments, and engagement platform designed to address three foundational challenges in healthcare delivery: access to care, affordability of care, and patient health outcomes. Its platform is embedded directly into provider workflows and patient interactions, enabling healthcare organizations to activate patients, streamline administrative processes, and improve financial performance across the care continuum. The group serves a diverse group of healthcare organizations, including ambulatory practices, health systems, and hospitals, as well as life sciences companies, government entities, patient advocacy, public interest, and not-for-profit and other organizations.
65GF Score
Get the complete analysis for PHR
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PHR has been successfully added to your 
